Argent Trust Co’s PDL BioPharma, Inc. PDLI Stock Holding History

Argent Trust Co’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	41,405	–	–	﹤0.01%	735
2025 Q4	$0	Hold	41,405	–	–	﹤0.01%	719
2025 Q3	$0	Hold	41,405	–	–	﹤0.01%	718
2025 Q2	$0	Hold	41,405	–	–	﹤0.01%	736
2025 Q1	$0	Hold	41,405	–	–	﹤0.01%	738
2024 Q4	$0	Hold	41,405	–	–	﹤0.01%	733
2024 Q3	$0	Hold	41,405	–	–	﹤0.01%	737
2024 Q2	$0	Hold	41,405	–	–	﹤0.01%	738
2024 Q1	$0	Hold	41,405	–	–	﹤0.01%	711
2023 Q4	$102K	Hold	41,405	–	–	0.01%	606
2023 Q3	$102K	Hold	41,405	–	–	0.01%	592
2023 Q2	$102K	Buy	+41,405	New	+$102K	0.01%	615

Other funds holding PDLI

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Argent Trust Co's PDLI Position: Q1 2026 in Review

Argent Trust Co held its PDL BioPharma, Inc. (PDLI) position steady in Q1 2026 at 41,405 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #735.

Argent Trust Co first reported a position in PDLI in Q2 2023 and has held it in 12 quarters since. The position peaked at $102K in Q4 2023. 6 funds tracked by Wall St. Rank hold PDLI as of Q1 2026.

Argent Trust Co held 41,405 shares of PDL BioPharma, Inc. worth $0 as of Q1 2026.
Argent Trust Co left its PDL BioPharma, Inc. share count unchanged in Q1 2026.
PDL BioPharma, Inc. made up ﹤0.01% of Argent Trust Co's portfolio in Q1 2026, its #735 holding.
Argent Trust Co first reported a position in PDL BioPharma, Inc. in Q2 2023 and has held it in 12 quarters since.
Argent Trust Co's PDL BioPharma, Inc. position peaked at $102K in Q4 2023.
6 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.